We use novel data from a survey of nearly 750 corporate executives to study the effects of artificial intelligence (AI) on productivity and the workforce. We document substantial heterogeneity in AI adoption across firms, with more than half having already invested, though many smaller firms are...

The Independent Evaluation Group’s (IEG) Artificial Intelligence (AI) strategy marks an important milestone in its journey of continuous experimentation, learning, and adaptation to integrate AI in evaluation. It reaffirms IEG's commitment to scale up the use of AI, deliberately and...

Companies, not governments, are at the cutting edge of developing new artificial intelligence (AI) technologies for military use, and regulation needs to keep pace with these advances. Yet geopolitical tension is undermining international cooperation on AI in the military domain. This paper...

The rapid evolution of artificial intelligence (AI) from expert systems and fuzzy logic to sophisticated technologies such as deep learning and big data analytics has transformed modern management practices. This study explores how AI-driven management practices can effectively bridge...

Background: The extraordinary disturbances faced by the hotel industry, ranging from worldwide health problems to political instability and climate change, have highlighted the insistent need for more resilient and agile supply chain (SC) systems. This study explored how artificial intelligence...

Generative artificial intelligence (GenAI), with its potential to autonomously generate new content in the form of text, video, audio and code, holds disruptive potential to revolutionize knowledge management (KM) processes. An enormous number of studies have been published in recent years on...

This study evaluates the reforms proposed by the Ministry of Social Affairs and Health for the earnings-related pension system in the 2025 legislative proposal. The proposed reform would allow private-sector pension institutions to take on greater investment risk. According to Etla's assessment,...

Die Online-Plattform TrumpRx (www.trumprx.gov) wurde 2026 von der US-Bundesregierung eingeführt, um US-Bürgerinnen und -Bürgern verschreibungspflichtige Medikamente zu deutlich reduzierten Preisen anzubieten. Bei internationalen Preisvergleichen liegen die amerikanischen Preise zumindest bei...